CD103+/PD-1+T-cells identify a subset of triple-negative breast cancer eligible for targeted checkpoint inhibition

被引：0
|
作者：
Bottai, G.
Loi, S.
Sotiriou, C.
Roncalli, M.
Pusztai, L.
Reis-Filho, J. S.
Santarpia, L.
机构：
[1] Humanitas Clin & Res Ctr, Milan, Italy
[2] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[3] Inst Jules Bordet, Brussels, Belgium
[4] Humanitas Univ, Milan, Italy
[5] Yale Canc Ctr, New Haven, CT USA
[6] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-P2-04-16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-04-16
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Immune Checkpoint Inhibition for Triple-Negative Breast Cancer: Current Landscape and Future Perspectives
    Yi, Huimei
    Li, Ying
    Tan, Yuan
    Fu, Shujun
    Tang, Faqing
    Deng, Xiyun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [22] Adoptive Transfer of Anti-Nucleolin T Cells Combined with PD-L1 Inhibition against Triple-Negative Breast Cancer
    Thongchot, Suyanee
    Jirapongwattana, Niphat
    Luangwattananun, Piriya
    Chiraphapphaiboon, Wannasiri
    Chuangchot, Nisa
    Sa-Nguanraksa, Doonyapat
    O-Charoenrat, Pornchai
    Thuwajit, Peti
    Yenchitsomanus, Pa-Thai
    Thuwajit, Chanitra
    MOLECULAR CANCER THERAPEUTICS, 2022, 21 (05) : 727 - 739
  • [23] Immune-checkpoint inhibition for metastatic triple-negative breast cancer: safety first?
    Nina D’Abreo
    Sylvia Adams
    Nature Reviews Clinical Oncology, 2019, 16 : 399 - 400
  • [24] PD-L1 Expression in Triple-Negative Breast Cancer
    Mittendorf, Elizabeth A.
    Philips, Anne V.
    Meric-Bernstam, Funda
    Qiao, Na
    Wu, Yun
    Harrington, Susan
    Su, Xiaoping
    Wang, Ying
    Gonzalez-Angulo, Ana M.
    Akcakanat, Argun
    Chawla, Akhil
    Curran, Michael
    Hwu, Patrick
    Sharma, Padmanee
    Litton, Jennifer K.
    Molldrem, Jeffrey J.
    Alatrash, Gheath
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (04) : 361 - 370
  • [25] Association PD-L1 overexpression with immune checkpoint inhibitor effect in triple-negative breast cancer
    Park, A. Young
    Kim, Ju Hee
    Lee, Sangen
    Kim, Hong Kyu
    Lee, Han-Byoel
    Han, Wonshick
    CANCER RESEARCH, 2023, 83 (07)
  • [26] Role of PD-L1 expression in triple-negative breast cancer stem cells
    Di Nicola, Massimo A.
    Castagnoli, Lorenzo
    Cancila, Valeria
    Romero, Sandra
    Faraci, Simona
    Chiodoni, Claudia
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [27] Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1
    Li, Chia-Wei
    Lim, Seung-Oe
    Chung, Ezra M.
    Kim, Yong-Soo
    Park, Andrew H.
    Yao, Jun
    Cha, Jong-Ho
    Xia, Weiya
    Chan, Li-Chuan
    Kim, Taewan
    Chang, Shih-Shin
    Lee, Heng-Huan
    Chou, Chao-Kai
    Liu, Yen-Liang
    Yeh, Hsin-Chih
    Perillo, Evan P.
    Dunn, Andrew K.
    Kuo, Chu-Wei
    Khoo, Kay-Hooi
    Hsu, Jennifer L.
    Wu, Yun
    Hsu, Jung-Mao
    Yamaguchi, Hirohito
    Huang, Tzu-Hsuan
    Sahin, Aysegul A.
    Hortobagyi, Gabriel N.
    Yoo, Stephen S.
    Hung, Mien-Chie
    CANCER CELL, 2018, 33 (02) : 187 - +
  • [28] Eradication of triple-negative breast cancer cells by targeting glycosylated PD-L1
    Lim, Seung-Oe
    Li, Chia-Wei
    Hung, Mien-Chie
    CANCER RESEARCH, 2018, 78 (13)
  • [29] The effect of cardamonin on PD-L1 expression in triple-negative breast cancer cells
    Mendonca, Patricia
    Kirpal, Bhonessa
    Kaur, Sukhmandeep
    Soliman, Karam F. A.
    CANCER RESEARCH, 2024, 84 (06)
  • [30] Supramolecular magnetonanohybrids for multimodal targeted therapy of triple-negative breast cancer cells
    Mansur, Alexandra A. P.
    Mansur, Herman S.
    Leonel, Alice G.
    Carvalho, Isadora C.
    Lage, Manuela C. G.
    Carvalho, Sandhra M.
    Krambrock, Klaus
    Lobato, Zelia I. P.
    JOURNAL OF MATERIALS CHEMISTRY B, 2020, 8 (32) : 7166 - 7188
12345